I. M. Hoepelman

1.9k citations

66 papers · 1.4k indexed · h-index 24

Epidemiology top 5%
Infectious Diseases top 5%
Pharmacology top 5%
Molecular Medicine top 5%
Public Health, Environmental and Occupational Health top 10%

Co-authors: J. Verhoef M. Rozenberg-Arska M. M. E. Schneider H.M. Beumer Jelle Scharringa Wendy Chaka A F Verheul Pauline M. Ellerbroek
Topics: Pneumonia and Respiratory Infections (15 papers)Antibiotic Resistance in Bacteria (12 papers)Antibiotics Pharmacokinetics and Efficacy (10 papers)
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Epidemiology
Journals: The Journal of Clinical Endocrinology & Metabolism Clinical Microbiology Reviews Journal of Clinical Microbiology
Partner nations: Netherlands United States Germany

In The Last Decade

I. M. Hoepelman

65 papers receiving 1.3k citations

Peers

Countries citing papers authored by I. M. Hoepelman

Since Specialization

Citations

This map shows the geographic impact of I. M. Hoepelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. M. Hoepelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. M. Hoepelman more than expected).

Fields of papers citing papers by I. M. Hoepelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. M. Hoepelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. M. Hoepelman. The network helps show where I. M. Hoepelman may publish in the future.

Co-authorship network of co-authors of I. M. Hoepelman

This figure shows the co-authorship network connecting the top 25 collaborators of I. M. Hoepelman. A scholar is included among the top collaborators of I. M. Hoepelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. M. Hoepelman. I. M. Hoepelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy 2006 ·European Journal of Pharmacology ·Blai Coll,J.P.H. van Wijk,Sandra Parra,Manuel Castro Cabezas,I. M. Hoepelman,Carlos Alonso‐Villaverde,Eelco J.P. de Koning,Jordi Camps,Natàlia Ferré,Ton J. Rabelink,Mònica Tous,Jorge Joven	35
2	Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia 2006 ·Clinical Microbiology and Infection ·(unknown),Jan Jelrik Oosterheert,E. Hak,I. M. Hoepelman,Marc J. M. Bonten	34
3	Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands 2005 ·Clinical Microbiology and Infection ·Jan Jelrik Oosterheert,Marc J. M. Bonten,M. M. E. Schneider,I. M. Hoepelman	9
4	In VivoEvidence of Impaired Peripheral Fatty Acid Trapping in Patients with Human Immunodeficiency Virus-Associated Lipodystrophy 2005 ·The Journal of Clinical Endocrinology & Metabolism ·J.P.H. van Wijk,Manuel Castro Cabezas,Eelco J.P. de Koning,Ton J. Rabelink,Rob J. van der Geest,I. M. Hoepelman	22
5	Computer-assisted decision support for the diagnosis and treatment of infectious diseases in intensive care units 2005 ·The Lancet Infectious Diseases ·(unknown),(unknown),I. M. Hoepelman,(unknown)	66
6	Do cultures contribute to optimisation of antibiotic therapy in the intensive care unit? 2004 ·International Journal of Antimicrobial Agents ·Carolina A. M. Schurink,(unknown),M. Rozenberg-Arska,Jos Joore,I. M. Hoepelman,Marc J. M. Bonten	7
7	Double-Blind, Placebo-Controlled Study Comparing the Effect of Azithromycin with Clarithromycin on Oropharyngeal and Bowel Microflora in Volunteers 2002 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown),Carolina A. M. Schurink,(unknown),A. Florijn,(unknown),I. M. Hoepelman	20
8	Long-Term Infectious Complications and Their Relation to Treatment Duration in Catheter-Related Staphylococcus aureus Bacteremia 2001 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown),C. A. J. J. Jaspers,Marian G.J. van Kraaij,M. R. Visser,I. M. Hoepelman	26
9	Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader 2000 ·Journal of Microbiological Methods ·Annemiek Walenkamp,Jelle Scharringa,(unknown),Frank E. J. Coenjaerts,I. M. Hoepelman	17
10	Cryptococcus neoformansand its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure 1999 ·FEMS Immunology & Medical Microbiology ·Annemiek Walenkamp,Wendy Chaka,A F Verheul,(unknown),Robert Cherniak,Frank E. J. Coenjaerts,I. M. Hoepelman	25
11	A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin–clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome 1998 ·International Journal of Antimicrobial Agents ·I. M. Hoepelman,(unknown),(unknown),A.P.M. Greefhorst,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),M. Rozenberg-Arska	53
12	Urineweginfecties bij patiënten met diabetes mellitus 1997 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·S.E. Geerlings,D.W. Erkelens,I. M. Hoepelman	2
13	Introduction 1996 ·International Journal of Antimicrobial Agents ·I. M. Hoepelman	0
14	Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1 1996 ·International Journal of Antimicrobial Agents ·M. M. E. Schneider,M Sprenger,I. M. Hoepelman,Yolanda van der Graaf,Jan C.C. Borleffs	6
15	Azithromycin: the first of the tissue-selective azalides 1995 ·International Journal of Antimicrobial Agents ·I. M. Hoepelman,M. M. E. Schneider	58
16	Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections 1993 ·European Journal of Clinical Microbiology & Infectious Diseases ·I. M. Hoepelman,(unknown),(unknown),(unknown),(unknown),(unknown),Tom A. Boon,M. R. Visser,F Asbeck,J. Verhoef	6
17	Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infections 1992 ·Infection ·(unknown),I. M. Hoepelman,J. Verhoef,(unknown),Tom A. Boon,(unknown),H.J.A. Mensink	4
18	Analysis ofEscherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping 1991 ·European Journal of Clinical Microbiology & Infectious Diseases ·Carin M. A. Rademaker,(unknown),Wouter Jansen,Nanda Vos,I. M. Hoepelman,M. Rozenberg-Arska,J. Verhoef	6
19	Once-daily aminoglycoside administration: New strategies for an old drug 1989 ·European Journal of Clinical Microbiology & Infectious Diseases ·John M. Kovarik,I. M. Hoepelman,J. Verhoef	43
20	Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea 1989 ·European Journal of Clinical Microbiology & Infectious Diseases ·Carin M. A. Rademaker,I. M. Hoepelman,M. J. H. M. Wolfhagen,H.M. Beumer,M. Rozenberg-Arska,J. Verhoef	64

About I. M. Hoepelman

I. M. Hoepelman is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 66 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (15 papers), Antibiotic Resistance in Bacteria (12 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (69 citations), Molecular Medicine (166 citations) and Epidemiology (698 citations). I. M. Hoepelman has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include J. Verhoef, M. Rozenberg-Arska, M. M. E. Schneider, H.M. Beumer, Jelle Scharringa, Wendy Chaka, A F Verheul, Pauline M. Ellerbroek, John M. Kovarik and Carin M. A. Rademaker. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Microbiology Reviews and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact